Safety implications of combined antiretroviral and anti-tuberculosis drugs
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety implications of combined antiretroviral and anti-tuberculosis drugs
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 19, Issue 1, Pages 23-41
Publisher
Informa UK Limited
Online
2019-12-07
DOI
10.1080/14740338.2020.1694901
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Linezolid pharmacokinetics in South African patients with drug resistant tuberculosis and a high prevalence of HIV co-infection
- (2019) Sean Wasserman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A lower dose of efavirenz can be co-administered with rifampicin and isoniazid in tuberculosis patients
- (2019) Julian P Kaboggoza et al. Open Forum Infectious Diseases
- A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis
- (2019) Andrew J. Nunn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rifampicin effect on intracellular and plasma pharmacokinetics of tenofovir alafenamide
- (2019) Maddalena Cerrone et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Dolutegravir-Based Antiretroviral Therapy for Patients Co-Infected with Tuberculosis and Hiv: A Multicenter, Noncomparative, Open-Label, Randomized Trial
- (2019) Kelly E Dooley et al. CLINICAL INFECTIOUS DISEASES
- Neuropsychiatric Adverse Events with Dolutegravir and Other Integrase Strand Transfer Inhibitors
- (2019) Christian Hoffmann et al. AIDS REVIEWS
- Adverse outcome pathway for aminoglycoside ototoxicity in drug-resistant tuberculosis treatment
- (2019) Hyejeong Hong et al. ARCHIVES OF TOXICOLOGY
- Pharmacokinetics of dolutegravir 100 mg once-daily with rifampicin
- (2019) Xinzhu Wang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug–Drug Interaction Study of Dolutegravir With Once-Weekly Isoniazid and Rifapentine
- (2018) Kristina M Brooks et al. CLINICAL INFECTIOUS DISEASES
- OUP accepted manuscript
- (2018) CLINICAL INFECTIOUS DISEASES
- Pharmacokinetic interaction between bedaquiline and clofazimine in patients with drug-resistant tuberculosis
- (2018) G. Maartens et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Long-acting formulations for the treatment of latent tuberculous infection: opportunities and challenges
- (2018) S. Swindells et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Multiple Doses of Rifabutin Reduce Exposure of Doravirine in Healthy Subjects
- (2018) Sauzanne G. Khalilieh et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study
- (2018) Gabriella Ferlazzo et al. LANCET INFECTIOUS DISEASES
- Risks of cardiovascular or central nervous system adverse events and immune reconstitution inflammatory syndrome, for dolutegravir versus other antiretrovirals
- (2018) Andrew M. Hill et al. Current Opinion in HIV and AIDS
- Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study
- (2018) Kathryn Schnippel et al. Lancet Respiratory Medicine
- Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception
- (2018) Rebecca Zash et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1
- (2018) Brinda Emu et al. NEW ENGLAND JOURNAL OF MEDICINE
- The tuberculosis-associated immune reconstitution inflammatory syndrome
- (2018) Naomi F. Walker et al. Current Opinion in HIV and AIDS
- Predictors of electrocardiographic QT interval prolongation in men with HIV
- (2018) Katherine C Wu et al. HEART
- Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS
- (2018) Graeme Meintjes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of drug-resistant tuberculosis among people living with HIV
- (2018) Rocío M. Hurtado et al. Current Opinion in HIV and AIDS
- Prolongation of the QTc interval in HIV-infected individuals compared to the general population
- (2017) Nico Reinsch et al. INFECTION
- Confirming model-predicted pharmacokinetic interactions between bedaquiline and lopinavir/ritonavir or nevirapine in patients with HIV and drug-resistant tuberculosis
- (2017) Margreke J.E. Brill et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- CD4 count and risk of anti-tuberculosis drug-associated cutaneous reactions in HIV-infected Thai patients
- (2017) L. Boonyagars et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Effect of rifampicin and efavirenz on moxifloxacin concentrations when co-administered in patients with drug-susceptible TB
- (2017) Anushka Naidoo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Prevalence and predictors of long corrected QT interval in HIV-positive patients
- (2017) Sebastiano Gili et al. Journal of Cardiovascular Medicine
- Current assessment of heart rate variability and QTc interval length in HIV/AIDS
- (2017) Roger C. McIntosh et al. Current Opinion in HIV and AIDS
- The risks of concurrent treatment with tenofovir and aminoglycosides in patients with HIV-associated tuberculosis
- (2017) Chris Kenyon et al. SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE
- Consensus statement: Management of drug-induced liver injury in HIV-positive patients treated for TB
- (2017) E Jong et al. SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE
- Delamanid Coadministered with Antiretroviral Drugs or Antituberculosis Drugs Shows No Clinically Relevant Drug-Drug Interactions in Healthy Subjects
- (2016) Suresh Mallikaarjun et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study
- (2016) Kathryn Schnippel et al. BMC INFECTIOUS DISEASES
- Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
- (2016) Payam Nahid et al. CLINICAL INFECTIOUS DISEASES
- A review of trials investigating efavirenz-induced neuropsychiatric side effects and the implications
- (2016) Razia Gaida et al. Expert Review of Anti-Infective Therapy
- Linezolid in the treatment of drug-resistant tuberculosis: the challenge of its narrow therapeutic index
- (2016) Sean Wasserman et al. Expert Review of Anti-Infective Therapy
- Frequency and risk factors of drug-induced liver injury during treatment of multidrug-resistant tuberculosis
- (2016) S. S. Lee et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Critical Review
- (2016) H. Manisha Yapa et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Drug–drug interactions between bedaquiline and the antiretrovirals lopinavir/ritonavir and nevirapine in HIV-infected patients with drug-resistant TB
- (2016) Mishal Pandie et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efavirenz Inhibits the Human Ether-A-Go-Go Related Current (hERG) and Induces QT Interval Prolongation inCYP2B6*6*6Allele Carriers
- (2016) AHMED M. ABDELHADY et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Predicting the Unpredictable
- (2016) Peter J. Schwartz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in antiretroviral regimens for HIV-1 therapy
- (2016) Huilian Wang et al. MEDICINE
- Inhibitory potential of tuberculosis drugs on ATP-binding cassette drug transporters
- (2016) Lindsey H.M. te Brake et al. TUBERCULOSIS
- Evaluation of pharmacokinetic interactions between long-acting HIV-1 fusion inhibitor albuvirtide and lopinavir/ritonavir, in HIV-infected subjects, combined with clinical study and simulation results
- (2016) Wanqiu Yang et al. XENOBIOTICA
- Linezolid-Associated Optic Neuropathy in Drug-Resistant Tuberculosis Patients in Mumbai, India
- (2016) Salil Mehta et al. PLoS One
- Bactericidal Activity of Pyrazinamide and Clofazimine Alone and in Combinations with Pretomanid and Bedaquiline
- (2015) Andreas H. Diacon et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis
- (2015) Olalekan A. Uthman et al. ANNALS OF INTERNAL MEDICINE
- Inhibitory Potential of Twenty Five Anti-tuberculosis Drugs on CYP Activities in Human Liver Microsomes
- (2015) Yoshihiko Shimokawa et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Mitochondrial (dys)function - a factor underlying the variability of efavirenz-induced hepatotoxicity?
- (2015) M Polo et al. BRITISH JOURNAL OF PHARMACOLOGY
- Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention
- (2015) Anthony T. Podany et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naïve HIV-Infected Patients: Results of the ENCORE1 Study
- (2015) L Dickinson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Safety and Tolerability Profile of Second-Line Anti-Tuberculosis Medications
- (2015) Geetha Ramachandran et al. DRUG SAFETY
- Linezolid for multidrug-resistant tuberculosis in HIV-infected and -uninfected patients
- (2015) Jennifer Hughes et al. EUROPEAN RESPIRATORY JOURNAL
- Paradoxical TB-IRIS in HIV-infected adults: a systematic review and meta-analysis
- (2015) Phiona E Namale et al. Future Microbiology
- Perspectives on tuberculosis in pregnancy
- (2015) Matthew Bates et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Susceptibility of N-acetyltransferase 2 slow acetylators to antituberculosis drug-induced liver injury: a meta-analysis
- (2015) Jing Shi et al. PHARMACOGENOMICS
- Association between antiretrovirals and thyroid diseases: a cross-sectional study
- (2015) Guilherme Almeida Rosa da Silva et al. Archives of Endocrinology Metabolism
- Comparative Study of the Effects of Antituberculosis Drugs and Antiretroviral Drugs on Cytochrome P450 3A4 and P-Glycoprotein
- (2014) Yasuhiro Horita et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phase I Safety, Pharmacokinetics, and Pharmacogenetics Study of the Antituberculosis Drug PA-824 with Concomitant Lopinavir-Ritonavir, Efavirenz, or Rifampin
- (2014) Kelly E. Dooley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Lopinavir-Ritonavir or Nevirapine on Bedaquiline Exposures and Potential Implications for Patients with Tuberculosis-HIV Coinfection
- (2014) Elin M. Svensson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Delamanid Does Not Inhibit or Induce Cytochrome P450 Enzymes in Vitro
- (2014) Yoshihiko Shimokawa et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Compassionate Use of Bedaquiline for the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Interim Analysis of a French Cohort
- (2014) L. Guglielmetti et al. CLINICAL INFECTIOUS DISEASES
- Prevalence, drug-induced hepatotoxicity, and mortality among patients multi-infected with HIV, tuberculosis, and hepatitis virus
- (2014) Pingzheng Mo et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Bedaquiline: a review of human pharmacokinetics and drug-drug interactions
- (2014) R. P. G. van Heeswijk et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial
- (2014) Sayoki G Mfinanga et al. LANCET INFECTIOUS DISEASES
- Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial
- (2014) Beatriz Grinsztejn et al. LANCET INFECTIOUS DISEASES
- Evaluation of Patterns of Liver Toxicity in Patients on Antiretroviral and Anti-Tuberculosis Drugs: A Prospective Four Arm Observational Study in Ethiopian Patients
- (2014) Getnet Yimer et al. PLoS One
- Prevalence and incidence of symmetrical symptomatic peripheral neuropathy in patients with multidrug-resistant TB
- (2014) F Conradie et al. SAMJ SOUTH AFRICAN MEDICAL JOURNAL
- Effects of rifampin-based antituberculosis therapy on plasma efavirenz concentrations in children vary by CYP2B6 genotype
- (2013) Helen M. McIlleron et al. AIDS
- Prevalence and Factors Associated with a Prolonged QTc Interval in a Cohort of Asymptomatic HIV-Infected Patients
- (2013) Tamara Moreno et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Risk of hepatotoxicity associated with fluoroquinolones: A national case–control safety study
- (2013) Thamir M. Alshammari et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Model-Based Estimates of the Effects of Efavirenz on Bedaquiline Pharmacokinetics and Suggested Dose Adjustments for Patients Coinfected with HIV and Tuberculosis
- (2013) Elin M. Svensson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Influence of efavirenz pharmacokinetics and pharmacogenetics on neuropsychological disorders in Ugandan HIV-positive patients with or without tuberculosis: a prospective cohort study
- (2013) Jackson K Mukonzo et al. BMC INFECTIOUS DISEASES
- Relationship Between Weight, Efavirenz Exposure, and Virologic Suppression in HIV-Infected Patients on Rifampin-Based Tuberculosis Treatment in the AIDS Clinical Trials Group A5221 STRIDE Study
- (2013) Anne F. Luetkemeyer et al. CLINICAL INFECTIOUS DISEASES
- Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients
- (2013) Mathieu S. Bolhuis et al. EUROPEAN RESPIRATORY JOURNAL
- Safety of cycloserine and terizidone for the treatment of drug-resistant tuberculosis: a meta-analysis [Review article]
- (2013) T. J. Hwang et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Tuberculosis Immune Reconstitution Inflammatory Syndrome in A5221 STRIDE
- (2013) Anne F. Luetkemeyer et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Safety of rifabutin replacing rifampicin in the treatment of tuberculosis: a single-centre retrospective cohort study
- (2013) J.-Y. Chien et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacokinetic interaction of rifapentine and raltegravir in healthy volunteers
- (2013) M. Weiner et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection
- (2013) Sharon L. Walmsley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Non-nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerability
- (2013) Iris Usach et al. Journal of the International AIDS Society
- Central Nervous System Immune Reconstitution Inflammatory Syndrome
- (2013) Nathan Bahr et al. Current Infectious Disease Reports
- Impact of Pharmacogenetic Markers of CYP2B6, Clinical Factors, and Drug-Drug Interaction on Efavirenz Concentrations in HIV/Tuberculosis-Coinfected Patients
- (2012) W. Manosuthi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tuberculosis in Pregnant and Postpartum Women: Epidemiology, Management, and Research Gaps
- (2012) J. S. Mathad et al. CLINICAL INFECTIOUS DISEASES
- Safety and Pharmacokinetics of Escalating Daily Doses of the Antituberculosis Drug Rifapentine in Healthy Volunteers
- (2012) K E Dooley et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cutaneous adverse drug reactions to anti-tuberculosis drugs: state of the art and into the future
- (2012) Rannakoe J Lehloenya et al. Expert Review of Anti-Infective Therapy
- Hepatotoxicity during treatment for multidrug-resistant tuberculosis: occurrence, management and outcome
- (2012) S. Keshavjee et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Rilpivirine: a new non-nucleoside reverse transcriptase inhibitor
- (2012) M. Sharma et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury
- (2012) Harshad Devarbhavi et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India
- (2012) Petros Isaakidis et al. PLoS One
- A Comparison between Two Strategies for Monitoring Hepatic Function during Antituberculous Therapy
- (2011) Aran Singanayagam et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pharmacokinetics of Lopinavir in HIV-Infected Adults Receiving Rifampin with Adjusted Doses of Lopinavir-Ritonavir Tablets
- (2011) Eric H. Decloedt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Complex Drug Interactions of HIV Protease Inhibitors 1: Inactivation, Induction, and Inhibition of Cytochrome P450 3A by Ritonavir or Nelfinavir
- (2011) B. J. Kirby et al. DRUG METABOLISM AND DISPOSITION
- The influence of tuberculosis treatment on efavirenz clearance in patients co-infected with HIV and tuberculosis
- (2011) Tanuja N. Gengiah et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Safety, Tolerability, and Pharmacokinetic Interactions of the Antituberculous Agent TMC207 (Bedaquiline) With Efavirenz in Healthy Volunteers
- (2011) Kelly E. Dooley et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings
- (2011) Kevin Robertson et al. JOURNAL OF NEUROVIROLOGY
- Hepatitis Associated With Prothionamide for Treatment of Multidrug-resistant Tuberculosis
- (2011) Han-Lin Hsu et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Integration of Antiretroviral Therapy with Tuberculosis Treatment
- (2011) Salim S. Abdool Karim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Earlier versus Later Start of Antiretroviral Therapy in HIV-Infected Adults with Tuberculosis
- (2011) François-Xavier Blanc et al. NEW ENGLAND JOURNAL OF MEDICINE
- Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis
- (2011) Diane V. Havlir et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome
- (2010) Graeme Meintjes et al. AIDS
- Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis
- (2010) Armand Van Deun et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Hypersensitivity reactions to HIV therapy
- (2010) Mas Chaponda et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetic Interactions between Etravirine and Non-Antiretroviral Drugs
- (2010) Thomas N. Kakuda et al. CLINICAL PHARMACOKINETICS
- Nervous System Effects of Antituberculosis Therapy
- (2010) Joseph S. Kass et al. CNS DRUGS
- Unexpected Effect of Rifampin on the Pharmacokinetics of Linezolid: In Silico and In Vitro Approaches to Explain Its Mechanism
- (2010) Kuan Gandelman et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Neurologic disease burden in treated HIV/AIDS predicts survival: A population-based study
- (2010) P. Vivithanaporn et al. NEUROLOGY
- Pharmacology of second-line antituberculosis drugs and potential for interactions with antiretroviral agents
- (2009) Katherine M Coyne et al. AIDS
- HIV Coinfection in Multidrug- and Extensively Drug-Resistant Tuberculosis Results in High Early Mortality
- (2009) Neel R. Gandhi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Update on Rifampin and Rifabutin Drug Interactions
- (2009) Anne M. Baciewicz et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Isoniazid- and ethambutol-induced psychosis
- (2009) R Prasad et al. Annals of Thoracic Medicine
- Effect of Rifampin, a Potent Inducer of Drug-Metabolizing Enzymes, on the Pharmacokinetics of Raltegravir
- (2009) L. A. Wenning et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational Database
- (2009) Jialun Zhou et al. BMC INFECTIOUS DISEASES
- Adverse events to antituberculosis therapy: influence of HIV and antiretroviral drugs
- (2009) D J B Marks et al. INTERNATIONAL JOURNAL OF STD & AIDS
- Relationship between HIV protease inhibitors and QTc interval duration in HIV-infected patients: a cross-sectional study
- (2008) Beny Charbit et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A prospective study of antituberculous drug-induced hepatotoxicity in an area endemic for liver diseases
- (2008) Hoda A. Makhlouf et al. Hepatology International
- Outcomes of Nevirapine- and Efavirenz-Based Antiretroviral Therapy When Coadministered With Rifampicin-Based Antitubercular Therapy
- (2008) Andrew Boulle JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- HIV-Associated Tuberculosis: Diagnostic and Treatment Challenges
- (2008) Wafaa El-Sadr et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Antituberculosis drug-induced hepatotoxicity: Concise up-to-date review
- (2007) Alma Tostmann et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More